Prognia
Drug Database
🇪🇺EU · EMAAuthorisedATC: N05AX12

Abilify Maintena(aripiprazole)

Schizophrenia

Marketing Authorisation Holder: Otsuka Pharmaceutical Netherlands B.V.

EMA Authorisation: 14/11/2013

INN: aripiprazole

Indication

Maintenance treatment of schizophrenia in adult patients stabilised with oral aripiprazole.

Official EMA Resources

View on EMA (ema.europa.eu)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about Abilify Maintena — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.

Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.